model of a sdm adc Search Results


q5 sdm kit  (New England Biolabs)
99
New England Biolabs q5 sdm kit
Oligodeoxynucleotide design and utilization in the site-directed mutagenesis protocols. Three methods of <t>SDM</t> were utilized to establish the ability to produce PCR products for site-directed mutagenesis. Noncomplementary oligos contain the mutation on the forward oligo with the reverse oligo binding adjacent to the 5′ start of the forward oligo. Gentamicin resistance was conferred by a gentamicin acetyltransferase gene, aacC1. The targeted mutations reported here were selected to represent A/T contents ranging from ∼75% to ∼54%. Oligos are not drawn to scale.
Q5 Sdm Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/q5 sdm kit/product/New England Biolabs
Average 99 stars, based on 1 article reviews
q5 sdm kit - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier
sdm adc  (MathWorks Inc)
90
MathWorks Inc sdm adc
Oligodeoxynucleotide design and utilization in the site-directed mutagenesis protocols. Three methods of <t>SDM</t> were utilized to establish the ability to produce PCR products for site-directed mutagenesis. Noncomplementary oligos contain the mutation on the forward oligo with the reverse oligo binding adjacent to the 5′ start of the forward oligo. Gentamicin resistance was conferred by a gentamicin acetyltransferase gene, aacC1. The targeted mutations reported here were selected to represent A/T contents ranging from ∼75% to ∼54%. Oligos are not drawn to scale.
Sdm Adc, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sdm adc/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
sdm adc - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
computer screen sony sdm p232w 23  (Sony)
90
Sony computer screen sony sdm p232w 23
Oligodeoxynucleotide design and utilization in the site-directed mutagenesis protocols. Three methods of <t>SDM</t> were utilized to establish the ability to produce PCR products for site-directed mutagenesis. Noncomplementary oligos contain the mutation on the forward oligo with the reverse oligo binding adjacent to the 5′ start of the forward oligo. Gentamicin resistance was conferred by a gentamicin acetyltransferase gene, aacC1. The targeted mutations reported here were selected to represent A/T contents ranging from ∼75% to ∼54%. Oligos are not drawn to scale.
Computer Screen Sony Sdm P232w 23, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/computer screen sony sdm p232w 23/product/Sony
Average 90 stars, based on 1 article reviews
computer screen sony sdm p232w 23 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
photometer sdm 5  (Minitube USA Inc)
90
Minitube USA Inc photometer sdm 5
Oligodeoxynucleotide design and utilization in the site-directed mutagenesis protocols. Three methods of <t>SDM</t> were utilized to establish the ability to produce PCR products for site-directed mutagenesis. Noncomplementary oligos contain the mutation on the forward oligo with the reverse oligo binding adjacent to the 5′ start of the forward oligo. Gentamicin resistance was conferred by a gentamicin acetyltransferase gene, aacC1. The targeted mutations reported here were selected to represent A/T contents ranging from ∼75% to ∼54%. Oligos are not drawn to scale.
Photometer Sdm 5, supplied by Minitube USA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/photometer sdm 5/product/Minitube USA Inc
Average 90 stars, based on 1 article reviews
photometer sdm 5 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
delivery solvent prostar 230 sdm  (Varian Medical)
90
Varian Medical delivery solvent prostar 230 sdm
Oligodeoxynucleotide design and utilization in the site-directed mutagenesis protocols. Three methods of <t>SDM</t> were utilized to establish the ability to produce PCR products for site-directed mutagenesis. Noncomplementary oligos contain the mutation on the forward oligo with the reverse oligo binding adjacent to the 5′ start of the forward oligo. Gentamicin resistance was conferred by a gentamicin acetyltransferase gene, aacC1. The targeted mutations reported here were selected to represent A/T contents ranging from ∼75% to ∼54%. Oligos are not drawn to scale.
Delivery Solvent Prostar 230 Sdm, supplied by Varian Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/delivery solvent prostar 230 sdm/product/Varian Medical
Average 90 stars, based on 1 article reviews
delivery solvent prostar 230 sdm - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
sorbitol  (British Pharmacopoeia)
86
British Pharmacopoeia sorbitol
Oligodeoxynucleotide design and utilization in the site-directed mutagenesis protocols. Three methods of <t>SDM</t> were utilized to establish the ability to produce PCR products for site-directed mutagenesis. Noncomplementary oligos contain the mutation on the forward oligo with the reverse oligo binding adjacent to the 5′ start of the forward oligo. Gentamicin resistance was conferred by a gentamicin acetyltransferase gene, aacC1. The targeted mutations reported here were selected to represent A/T contents ranging from ∼75% to ∼54%. Oligos are not drawn to scale.
Sorbitol, supplied by British Pharmacopoeia, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sorbitol/product/British Pharmacopoeia
Average 86 stars, based on 1 article reviews
sorbitol - by Bioz Stars, 2026-04
86/100 stars
  Buy from Supplier
prostar 230 sdm  (Varian Medical)
90
Varian Medical prostar 230 sdm
Oligodeoxynucleotide design and utilization in the site-directed mutagenesis protocols. Three methods of <t>SDM</t> were utilized to establish the ability to produce PCR products for site-directed mutagenesis. Noncomplementary oligos contain the mutation on the forward oligo with the reverse oligo binding adjacent to the 5′ start of the forward oligo. Gentamicin resistance was conferred by a gentamicin acetyltransferase gene, aacC1. The targeted mutations reported here were selected to represent A/T contents ranging from ∼75% to ∼54%. Oligos are not drawn to scale.
Prostar 230 Sdm, supplied by Varian Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prostar 230 sdm/product/Varian Medical
Average 90 stars, based on 1 article reviews
prostar 230 sdm - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Oligodeoxynucleotide design and utilization in the site-directed mutagenesis protocols. Three methods of SDM were utilized to establish the ability to produce PCR products for site-directed mutagenesis. Noncomplementary oligos contain the mutation on the forward oligo with the reverse oligo binding adjacent to the 5′ start of the forward oligo. Gentamicin resistance was conferred by a gentamicin acetyltransferase gene, aacC1. The targeted mutations reported here were selected to represent A/T contents ranging from ∼75% to ∼54%. Oligos are not drawn to scale.

Journal: Journal of Biomolecular Techniques : JBT

Article Title: Method to Overcome Inefficiencies in Site-Directed Mutagenesis of A/T-Rich DNA

doi: 10.7171/jbt.20-3103-003

Figure Lengend Snippet: Oligodeoxynucleotide design and utilization in the site-directed mutagenesis protocols. Three methods of SDM were utilized to establish the ability to produce PCR products for site-directed mutagenesis. Noncomplementary oligos contain the mutation on the forward oligo with the reverse oligo binding adjacent to the 5′ start of the forward oligo. Gentamicin resistance was conferred by a gentamicin acetyltransferase gene, aacC1. The targeted mutations reported here were selected to represent A/T contents ranging from ∼75% to ∼54%. Oligos are not drawn to scale.

Article Snippet: We then tested the efficacy of a different SDM kit, Q5 SDM (New England BioLabs), because of its utilization of an alternate DNA polymerase with higher efficiency and an ability to accurately synthesize DNA that is A/T- or G/C-rich.

Techniques: Mutagenesis, Binding Assay

Electrophoretic separation, visualization, and relative concentration of site-directed mutagenesis products. SDM products were visualized following electrophoretic separation with 1.1% Tris, acetate, and EDTA (TAE) agarose gels. Loading controls of known linearized plasmid concentrations were used for densitometry to obtain relative concentrations of product. The SDM product lanes are unaltered PCR reactions; the treated product lanes are DpnI-digested or KLD-treated PCR reactions (KLD treatment is specific to Q5 SDM reactions only). Each triplicate series was visualized and electrophoresed independently from other triplicate series. Agarose gels were stained in an ethidium bromide bath for 45 min and destained for 30 min in deionized water. A) The QuikChange II protocol utilizing complementary oligos. B) The Q5 SDM protocol utilizing nonoverlapping oligos. C) The A/T-rich SDM protocol utilizing complementary oligos as described for the QuikChange II protocol. D) Relative concentrations of product generated determined using the Image Lab software from Bio-Rad and the known loading controls. Control reactions for the QuikChange II protocol were not resolvable by gel electrophoresis. Results are reported as a mean of 3 trials with sd. The same standards were used to determine product concentrations of all 3 trials. Concentrations were estimated using densitometry values and dividing by 15 (the volume of each reaction loaded).

Journal: Journal of Biomolecular Techniques : JBT

Article Title: Method to Overcome Inefficiencies in Site-Directed Mutagenesis of A/T-Rich DNA

doi: 10.7171/jbt.20-3103-003

Figure Lengend Snippet: Electrophoretic separation, visualization, and relative concentration of site-directed mutagenesis products. SDM products were visualized following electrophoretic separation with 1.1% Tris, acetate, and EDTA (TAE) agarose gels. Loading controls of known linearized plasmid concentrations were used for densitometry to obtain relative concentrations of product. The SDM product lanes are unaltered PCR reactions; the treated product lanes are DpnI-digested or KLD-treated PCR reactions (KLD treatment is specific to Q5 SDM reactions only). Each triplicate series was visualized and electrophoresed independently from other triplicate series. Agarose gels were stained in an ethidium bromide bath for 45 min and destained for 30 min in deionized water. A) The QuikChange II protocol utilizing complementary oligos. B) The Q5 SDM protocol utilizing nonoverlapping oligos. C) The A/T-rich SDM protocol utilizing complementary oligos as described for the QuikChange II protocol. D) Relative concentrations of product generated determined using the Image Lab software from Bio-Rad and the known loading controls. Control reactions for the QuikChange II protocol were not resolvable by gel electrophoresis. Results are reported as a mean of 3 trials with sd. The same standards were used to determine product concentrations of all 3 trials. Concentrations were estimated using densitometry values and dividing by 15 (the volume of each reaction loaded).

Article Snippet: We then tested the efficacy of a different SDM kit, Q5 SDM (New England BioLabs), because of its utilization of an alternate DNA polymerase with higher efficiency and an ability to accurately synthesize DNA that is A/T- or G/C-rich.

Techniques: Concentration Assay, Mutagenesis, Plasmid Preparation, Staining, Generated, Software, Nucleic Acid Electrophoresis

Site-directed mutagenesis results

Journal: Journal of Biomolecular Techniques : JBT

Article Title: Method to Overcome Inefficiencies in Site-Directed Mutagenesis of A/T-Rich DNA

doi: 10.7171/jbt.20-3103-003

Figure Lengend Snippet: Site-directed mutagenesis results

Article Snippet: We then tested the efficacy of a different SDM kit, Q5 SDM (New England BioLabs), because of its utilization of an alternate DNA polymerase with higher efficiency and an ability to accurately synthesize DNA that is A/T- or G/C-rich.

Techniques: Mutagenesis